Bill Sponsor
House Bill 2881
117th Congress(2021-2022)
Medicare Buy-In and Health Care Stabilization Act of 2021
Introduced
Introduced
Introduced in House on Apr 28, 2021
Overview
Text
Introduced
Apr 28, 2021
Latest Action
Apr 29, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2881
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
New York
Democrat
California
Democrat
Connecticut
Democrat
Connecticut
Democrat
Hawaii
Democrat
Kentucky
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Medicare Buy-In and Health Care Stabilization Act of 2021

This bill establishes a Medicare buy-in option for certain qualifying individuals and makes a series of other changes relating to health care costs.

Specifically, the bill allows individuals aged 50 to 64 to enroll in Medicare if such individuals would otherwise qualify for Medicare at the age of 65. The Centers for Medicare & Medicaid Services (CMS) must determine enrollment periods and set premiums for the buy-in option established under the bill, in accordance with specified requirements. The CMS must also award grants to states and nonprofit organizations for outreach and enrollment activities relating to the buy-in option.

The bill also (1) establishes a supplemental option under Medicare to cover cost-sharing for beneficiaries; (2) repeals provisions that prohibit the CMS from negotiating the prices of prescription drugs; (3) establishes an individual market reinsurance program relating to coverage of high-cost individuals, as specified; and (4) makes permanent certain increases and expansions of the premium tax credit.

Text (1)
April 28, 2021
Actions (5)
04/29/2021
Referred to the Subcommittee on Health.
04/28/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
04/28/2021
Referred to the Subcommittee on Health.
04/28/2021
Referred to the Subcommittee on Social Security.
04/28/2021
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:48:33 PM